Myokardinfarkt und kardiogener Schock

Schlüsselwörter

kardiogener Schock - Myokardinfarkt - Revaskularisation - intraaortele Ballonpumpe - Inotropika - Vasopressoren

Keywords

Cardiogenic shock - myocardial infarction - intraortic ballon pump - inotropic support - vasopressor support

• Literatur

• 1 Alexander JH, Reynolds HR, Stebbins AL et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 2007; 297: 1657-1666
• 2 Annane D, Vignon P, Renault A et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007; 370: 676-684
• 3 Beurtheret S, Mordant P, Paoletti X et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J 2012; 34: 112-120
• 4 Buerke M, Murohara T, Lefer AM. Cardioprotective Effects of a C1 Esterase Inhibitor in Myocardial Ischemia and Reperfusion. Circulation 1995; 91: 393-402
• 5 Buerke M, Prüfer D, Dahm M et al. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J Pharmacol Exp Ther 1998; 286: 429-438
• 6 Buerke M, Schwertz H, Seitz W et al. Novel small molecule inhibitor of C1s exerts cardioprotective effects in ischemia-reperfusion injury in rabbits. J Immunol 2001; 167: 5375-80
• 7 Buerke M, Lemm H, Dietz S et al. Infarktbedingter kardiogener Schock Ursache, Diagnose und Behandlung. Intensivmed 2010; 47: 597-611
• 8 Cohen M, Urban P, Christenson JT et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark(R) Registry. Eur Heart J 2003; 24: 1763-1770
• 9 Fuhrmann JT, Schmeisser A, Schulze MR et al. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med 2008; 36: 2257-2266
• 10 Granger CB, Mahaffey KW, Weaver WD et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation 2003; 108: 1184-1190
• 11 Hannan EL, Samadashvili Z, Walford G et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv 2010; 3: 22-31
• 12 Hochman JS, Sleeper LA, Webb JG et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341: 625-634
• 13 Hochman JS, Sleeper LA, Webb JG et al. Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial Infarction. JAMA 2006; 295: 2511-2515
• 14 Meyer J, Merx W, Dörr R et al. Successful treatment of acute myocardial infarction shock by combined percutaneous tranluminal coronary recanalization (PTCR) and percutaneous tranluminal coronary angioplasty (PTCA). Am Heart J 1982; 103: 132-134
• 15 Prondzinsky R, Unverzagt S, Lemm H et al. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol 2012; 101: 375-384
• 16 Prondzinsky R, Unverzagt S, Russ M et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock 2012; 37: 378-384
• 17 Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008; 117: 686-697
• 18 Rupprecht HJ, vom Dahl J, Terres W et al. Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation 2000; 101: 2902-2908
• 19 Russ MA, Prondzinsky R, Christoph A et al. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 2007; 35: 2732-2739
• 20 Russ MA, Prondzinsky R, Carter JM et al. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan. Crit Care Med 2009; 37: 3017-3023
• 21 Steg PG, James SK, Atar D et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619
• 22 Thiele H, Schuler G, Neumann FJ et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 2012; 163: 938-945
• 23 Werdan K, Ruß M, Buerke M et al. Deutsch-österreichische S3-Leitlinie Infarktbedingter kardiogener Schock. Diagnose, Monitoring und Therapie. Intensivmedizin und Notfallmedizin 2011; 48: 291-344
• 24 Wijns W, Kolh P, Danchin N et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-2555